跳至主要内容
临床试验/NCT06071754
NCT06071754已完成不适用

Validation of the Performance of the Electrocardiogram (ECG) Function in the Masimo INVSENSOR00057

Masimo Corporation8 个研究点 分布在 1 个国家目标入组 365 人开始时间: 2023年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
365
试验地点
8
主要终点
Validation of the Performance of the Electrocardiogram (ECG) Function in the Masimo INVSENSOR00057

研究概览

简要总结

The objective of this study is to validate the performance of the electrocardiogram (ECG) function of the Masimo INVSENSOR00057 against contemporaneous measurements

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is 22 years of age or older
  • Subject is comfortable to read and communicate in English*
  • Subject belongs to one of two groups:
  • Subjects without any prior arrhythmia diagnosis presenting in normal sinus rhythm (Group1)
  • Subjects with history of paroxysmal or persistent atrial fibrillation presenting in atrial fibrillation (Group 2) *This is to ensure the subject can provide informed consent (as Masimo INVSENSOR00057 ECG study materials are currently available in English only) and can comply with study procedures.

排除标准

  • Subjects who are physically unable to wear a wristwatch
  • Subjects whose skin is not intact (e.g., has open wounds, has inflamed tattoos or piercings, has visible healing wounds) in or at the vicinity of the device placement site.
  • Subjects with an implantable defibrillator or cardiac pacing device.
  • Subjects with a skin condition which would preclude proper ECG electrode placement..
  • Subjects with known allergic reactions to adhesive tapes or ECG gel.
  • Subjects previously diagnosed with non-atrial fibrillation cardiac arrhythmia.
  • Subjects not suitable for the investigation at the discretion of the investigator or the clinical team

结局指标

主要结局

Validation of the Performance of the Electrocardiogram (ECG) Function in the Masimo INVSENSOR00057

时间窗: Approximately 30 minutes

Single Lead ECG, similar to lead I, intended to be used for Heart Rate measurement and AFib detection

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验